The Adalimumab Biosimilar Market size was valued at an estimated USD 772.1 million in 2023 and is projected to skyrocket to approximately USD 3.87 billion by 2030, representing an impressive Compound Annual Growth Rate (CAGR) of 25.9% over the forecast period. Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30...